Results 181 to 190 of about 60,638 (316)

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure

ESC Heart Failure, Volume 12, Issue 3, Page 2023-2033, June 2025.
Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami, Yasuyuki Egami, Masaru Abe, Mizuki Osuga, Hiroaki Nohara, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masamichi Yano, Masami Nishino   +11 more
wiley   +1 more source

Hyperamylasemia and Diabetic Ketoacidosis

, 1974
David M. Goldberg
openalex   +1 more source

Treatment of diabetic ketoacidosis in dogs by continuous low-dose intravenous infusion of insulin [PDF]

, 1993
Douglass K. Macintire
openalex   +1 more source

The efficacy and safety of sodium‐glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure

ESC Heart Failure, Volume 12, Issue 3, Page 2087-2097, June 2025.
Abstract Aims Sodium‐glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) have demonstrated effectiveness in reducing cardiovascular death and heart failure hospitalization (HFH). However, the efficacy and safety of SGLT2 inhibitors in elderly patients with poor general status, such as very low bodyweight or low nutritional status, who are not included ...
Kenji Nakano, Kenji Kanenawa, Akihiro Isotani, Takashi Morinaga, Kaori Yamamoto, Norihisa Miyawaki, Euihong Ko, Miho Nakamura, Yuichi Tanaka, Kenichi Ishizu, Toru Morofuji, Masaomi Hayashi, Masato Fukunaga, Makoto Hyodo, Shinichi Shirai, Kenji Ando   +15 more
wiley   +1 more source

Mottling as an Early Sign of Euglycemic Ketoacidosis Induced by SGLT-2 Inhibitors. [PDF]

Eur J Case Rep Intern Med
Memeti B, Brombacher F, Perger L, Russmann S.   +3 more
europepmc   +1 more source

Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 2909-2919, June 2025.
Abstract Automated insulin delivery (AID) systems, which consist of an insulin pump, a continuous glucose monitoring system and a software algorithm to automate insulin delivery based on real time glycaemic data, are rapidly evolving. AID is now strongly recommended as the insulin delivery method of choice for people with type 1 diabetes.
Cari Berget, S. Francesca Annan, Torben Biester, Pratik Choudhary, Gregory P. Forlenza, Anne L. Peters, Eric Renard, Dorothee Deiss   +7 more
wiley   +1 more source

Prevalence of in-hospital mortality among adult patients with diabetic ketoacidosis in Ethiopia: a systematic review and meta-analysis of observational studies. [PDF]

Front Clin Diabetes Healthc
Addisu ZD, Demsie DG, Beyene DA, Tafere C.   +3 more
europepmc   +1 more source

Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets. [PDF]

Diabetes Obes Metab
Abstract Aims Ketogenic diets are used by individuals with obesity and type 2 diabetes for improved glycaemic control, reduced appetite and weight loss. However, the risks associated with higher ketone levels, including diabetic ketoacidosis (DKA), in individuals with and without diabetes are not well‐documented.
Roberts CGP, Athinarayanan SJ, Ratner RE, Umpierrez GE.   +3 more
europepmc   +2 more sources

Rhinocerebral Mucormycosis in a Patient with AIDS: A Complication of Diabetic Ketoacidosis Following Pentamidine Therapy [PDF]

, 1996
Vicente Abril, E. Ortega, Pilar Arnau i Segarra, Francisco Pedro, Vicente Sabater, A. Herrera   +5 more
openalex   +1 more source

Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin‐deficient phenotype: A real world analysis

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3176-3184, June 2025.
Abstract Aim Diabetic kidney disease (DKD) is a major complication of diabetes, including in insulin‐deficient phenotypes, yet data on kidney outcomes with sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in this population are limited. This study investigates the impact of SGLT2i on kidney outcomes in patients with insulin‐deficient diabetes using ...
Anat Tsur, Avivit Cahn, Lior Hanoch, Rena Pollack   +3 more
wiley   +1 more source